Fears over a drug that can be used to treat alcohol addiction are unfounded, according to its first ever systematic review, led by academics at The University of Manchester. Though the study [...]
NICE has said that a new drug for preventing migraine is not a cost-effective use of NHS resources, in recently-published draft guidance. The guidance looks at Erenumab (also called Aimovig and [...]
As preparation for the 2019 Northern Ireland Pharmacy Conference forges ahead, ensure that you remain firmly in the know by checking out the recently-released itinerary. Taking place on 28th [...]
The US Food and Drug Administration (FDA) has approved Ultomiris (ravulizumab) injection for the treatment of adult patients with paroxysmal nocturnal hemoglobinuria (PNH), a rare and [...]
Responding to the publication of the NHS Long Term Plan, National Pharmacy Association Chief Executive, Mark Lyonette, has said, ‘People access NHS care in community pharmacies more frequently [...]
Researchers recommend greater action to promote best practice as a new study has revealed a rise in prescriptions of opioids for treating chronic pain between 1998 and 2018. A review of opioid [...]
